Literature DB >> 17398299

Statins for primary prevention of coronary artery disease.

Ruth McPherson, Nihan Kavaslar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17398299     DOI： 10.1016/S0140-6736(07)60516-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  A century of cholesterol and coronaries: from plaques to genes to statins.

Authors:  Joseph L Goldstein; Michael S Brown
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

Review 2.  The rationale for initiating treatment of hypercholesterolemia in young adulthood.

Authors:  Daniel Steinberg
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

3.  Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population.

Authors:  Ilaria Guella; Rosanna Asselta; Diego Ardissino; Pier Angelica Merlini; Flora Peyvandi; Sekar Kathiresan; Pier Mannuccio Mannucci; Marco Tubaro; Stefano Duga
Journal:  J Lipid Res       Date:  2010-08-10       Impact factor: 5.922

4.  Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.

Authors:  Susan G Lakoski; Fang Xu; Gloria L Vega; Scott M Grundy; Manisha Chandalia; Chun Lam; Robert S Lowe; Michael E Stepanavage; Thomas A Musliner; Jonathan C Cohen; Helen H Hobbs
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

5.  Emerging LDL therapies: Using human genetics to discover new therapeutic targets for plasma lipids.

Authors:  Jonathan C Cohen
Journal:  J Clin Lipidol       Date:  2013-03-26       Impact factor: 4.766

6.  PCSK9: a convertase that coordinates LDL catabolism.

Authors:  Jay D Horton; Jonathan C Cohen; Helen H Hobbs
Journal:  J Lipid Res       Date:  2008-11-19       Impact factor: 5.922
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.